Hasil Pencarian

✨ 4 results found - Searched 21143 records in 4ms.
cover

Skripsi

Hasil Pemeriksaan Immuno-Chromatography Test (ICT) LD Bio Aspergillus dibandingkan dengan IgG spesifik Aspergillus pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) di RSUP Persahabatan
2020 | BY Asiyah Taqiyya Fakhrur Razi - Jamal Zaini
  • Comparison of Immuno-Chromatography Test (ICT) LD Bio Aspergillus with Aspergillus-specific lgG in Non-Small Cell Lung Cancer (NSCLC) Patients at Persahabatan General Hospital.
  • Nomor Panggil S20164fk
cover

Disertasi

Peran MiR-10b, MiR-21, SuPAR dan PAI-1 Sebagai Prediktor Respons Terapi dan Progresivitas pada Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK).
2017 | BY Lyana Setiawan - Noorwati Sutandyo - Siti Boedina Kresno - Rahajuningsih Setiabudy
  • The Role of MiR-10b, MiR-21, Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), and Plasminogen Activator Inhibitor (PAI)-1 as Predictors of Treatment Response and Progressivity in Non-Small Cell Lung Cancer (NSCLC).
  • Nomor Panggil D17020fk
cover

Tesis

Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti
  • The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
  • Nomor Panggil T23187fk
cover

Tesis

Efikasi dan Toksisiti Erlotinib/Gefitinib sebagai Terapi Lini Kedua Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil
2015 | BY Sita Laksmi Andarini - Jamaluddin M. - Achmad Hudoyo
  • Efficacy and Toxicity Erlotinib/Gefitinib as Second Line Therapy in Non-Small Cell Lung Cancer Patients.
  • Nomor Panggil T 15 543 FK